Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials | Zendy

ChihCheng Lai | Zendy; ChaoHsien Chen | Zendy; ChengYi Wang | Zendy; Kuang-Hung Chen | Zendy; YaHui Wang | Zendy; PoRen Hsueh | Zendy

Open Access

Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials

Author(s) -

ChihCheng Lai,

ChaoHsien Chen,

ChengYi Wang,

Kuang-Hung Chen,

YaHui Wang,

PoRen Hsueh

Publication year - 2021

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkab093

Subject(s) - medicine , meta analysis , randomized controlled trial , placebo , cochrane library , covid-19 , adverse effect , clinical trial , confidence interval , medline , disease , pathology , alternative medicine , political science , infectious disease (medical specialty) , law

We performed a systematic review and network meta-analysis of randomized controlled trials (RCTs) to provide updated information regarding the clinical efficacy of remdesivir in treating coronavirus disease 2019 (COVID-19).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research